Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
about
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprololMyocardial strain imaging: how useful is it in clinical decision making?The Crossroads of Geriatric Cardiology and Cardio-OncologyGetting to the Heart of the Matter: An Overview of Cardiac Toxicity Related to Cancer TherapyThe year 2014 in the European Heart Journal – Cardiovascular Imaging. Part ICardiac risk in the treatment of breast cancer: assessment and management.Is it possible to cure childhood acute myeloid leukaemia without significant cardiotoxicity?Is 2D speckle tracking echocardiography useful for detecting and monitoring myocardial dysfunction in adult m.3243A>G carriers? - a retrospective pilot studyTranscatheter aortic valve implantation in a cancer patient denied for surgical aortic valve replacement-a case report.Two-dimensional strain echocardiography for detection of cardiotoxicity in breast cancer patients undergoing chemotherapy.Cardio-oncology: what you need to know now for clinical practice and echocardiography.Cardio-Oncology: Cancer Therapy-related Cardiovascular Complications in a Molecular Targeted Era: New Concepts and Perspectives.2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by represAn International Survey of Health Care Providers Involved in the Management of Cancer Patients Exposed to Cardiotoxic Therapy.Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis.Serum GDF15 Levels Correlate to Mitochondrial Disease Severity and Myocardial Strain, but Not to Disease Progression in Adult m.3243A>G Carriers.Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer.Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging.Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 2: Prevention, Treatment, Guidelines, and Future Directions.Cardiovascular Complications of Hematopoietic Stem Cell Transplantation.Early change in left atrial function in patients treated with anthracyclines assessed by real-time three-dimensional echocardiography.Cardiotoxicity and Cardiac Monitoring During Adjuvant Trastuzumab in Daily Dutch Practice: A Study of the Southeast Netherlands Breast Cancer Consortium.Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study--A Single-Center, Blinded, Randomized Controlled Trial.A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of CardiologyThe Early Predictive Value of Right Ventricular Strain in Epirubicin-Induced Cardiotoxicity in Patients with Breast Cancer.Global longitudinal strain: a useful everyday measurement?Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle tracking.The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytes.Cardiotoxicity Following Cancer Treatment.Accuracy of left ventricular ejection fraction by contemporary multiple gated acquisition scanning in patients with cancer: comparison with cardiovascular magnetic resonance.EACVI/HFA Cardiac Oncology Toxicity Registry in breast cancer patients: rationale, study design, and methodology (EACVI/HFA COT Registry)--EURObservational Research Program of the European Society of Cardiology.E-learning in cardiovascular imaging: another step towards a structured educational approach.Stress echocardiography: what is new and how does it compare with myocardial perfusion imaging and other modalities?Cardiovascular imaging practice in Europe: a report from the European Association of Cardiovascular Imaging.Cardiotoxicity due to Chemotherapy: the Role of Biomarkers.Heart failure and chemotherapeutic agents.Cardiac Imaging: Multimodality Advances and Surveillance Strategies in Detection of Cardiotoxicity.Normal references of right ventricular strain values by two-dimensional strain echocardiography according to the age and gender.Cardio-oncology: Gaps in Knowledge, Goals, Advances, and Educational Efforts.
P2860
Q26768272-2BB5D033-4204-4843-9BCF-45DFB54EC3B7Q26778343-70B6E2F9-6283-4FD9-A3D5-21D84403D0CDQ26778666-F80D58D2-FF0E-44DA-9E91-741AFC1C229DQ26797138-33B7EAAF-9BB9-4763-823D-0B04B9B26F06Q26853494-699BFEB2-839B-443F-B18A-97DE41BE84A0Q28081385-313D5D4E-F0AA-4FBB-859C-9E4F85D2C7F2Q30244600-1E17A830-8701-4965-84A6-5B22F216ABC2Q30362604-EF78ED56-3F4B-40B5-81CA-9C8840F86A10Q30570759-0B2EB60A-B23F-4786-A395-1983590AC50EQ33593674-A42CCE65-590D-4C0F-A6D5-4B69D62FB9B4Q33701308-EA72B0AC-BFD7-474A-B120-1CFA7D468083Q33807542-1C4D35E2-8299-43ED-8C12-A269D918F3C1Q34046881-21EE12A3-0BF2-4D96-BB4C-155D5244CB1EQ35957908-73A388E0-34A0-4996-8F13-13766ECD5465Q36085651-CB468DD5-E4DF-4E59-8063-96EEECF44EB7Q36090550-22407712-579C-44E4-8B84-2388F0DD10F5Q36095018-A93C69BF-4799-4F17-BBC0-C6B8B9993982Q36212048-776E8F42-3DA6-4D4D-9E89-AE4C82EE03E3Q36451899-B565C974-8DE2-448B-AF16-E70A5DB63B52Q36551901-FD85B22F-AFAE-48FF-83C7-4CBE53C2F490Q36615092-906F2C27-0900-49D4-A765-0D094644CDB2Q36872695-7A96CE59-4A9D-4D06-8E1F-58015A6D0966Q36884357-F03A9ADF-F06D-4378-AB25-56C9379629B9Q36894836-39C0E19B-7948-43C5-B954-DEC49ECAB7B5Q37052852-9DD8ED11-27E9-4A6B-BC5C-D4D054807FDDQ37314505-E3D78414-1CFD-4099-B9AF-7CE11A0F48FCQ37361224-5C4F7A2B-E170-4978-BCF4-8768EAEF2ECDQ37397983-8051A673-71DC-4652-8810-9F56CEA9EB7DQ37592520-05A4E983-E892-43AA-BD1A-E4C81AEF3064Q37663263-7C3DCB56-2F38-45DA-BC85-95D317DD0A91Q37719598-1812FCB8-133B-4B3D-B845-91192F900504Q38368230-BE93AE53-1A21-4571-A625-ADDE786F40A8Q38370243-69116834-F3F9-4A68-BF07-AAB0F859A541Q38441632-6EE372B4-1FBB-4007-8AC3-A5CDDE102D4DQ38461069-D184E09C-7622-45EB-AC01-C476BE8DCE02Q38508938-BF900463-2B38-43DE-9657-6D8DD25188A9Q38559133-CCB4BB65-60A7-41D6-AF45-856EEFB8FF24Q38632789-95C2F543-9AAB-422C-8C26-40F1276FCA62Q38656034-6D2DFECF-472F-40F1-A976-3B1AEDE01152Q38657849-0015D737-B7AF-40F3-987F-746349D3A2B7
P2860
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Expert consensus for multimoda ...... ion of Cardiovascular Imaging.
@ast
Expert consensus for multimoda ...... ion of Cardiovascular Imaging.
@en
type
label
Expert consensus for multimoda ...... ion of Cardiovascular Imaging.
@ast
Expert consensus for multimoda ...... ion of Cardiovascular Imaging.
@en
prefLabel
Expert consensus for multimoda ...... ion of Cardiovascular Imaging.
@ast
Expert consensus for multimoda ...... ion of Cardiovascular Imaging.
@en
P2093
P2860
P50
P921
P356
P1476
Expert consensus for multimoda ...... ion of Cardiovascular Imaging.
@en
P2093
Brian P Griffin
Deborah A Agler
Guy Jerusalem
Hector R Villarraga
Igal A Sebag
Javier Ganame
Jeanne M DeCara
Jennifer E Liu
P2860
P304
P356
10.1093/EHJCI/JEU192
P50
P577
2014-10-01T00:00:00Z